Report Library
View More
Datamonitor Healthcare Oncology Dis...
December 7, 2023
Datamonitor Healthcare CV&Met Disea...
December 6, 2023
Non-Small Cell Lung Cancer (NSCLC) ...
December 5, 2023
Non-Small Cell Lung Cancer (NSCLC) ...
December 5, 2023
Datamonitor Healthcare Oncology Dis...
December 5, 2023
Datamonitor Healthcare CV&Met: Obes...
December 5, 2023
Datamonitor Healthcare Oncology Dis...
December 4, 2023
Datamonitor Healthcare CV&Met: Isch...
December 1, 2023
Datamonitor Healthcare CV&Met Disea...
December 1, 2023
Datamonitor Healthcare Oncology: Tu...
December 1, 2023
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 12/5/23 | Merck KGaA (MKKGY) | Evobrutinib for Multiple Sclerosis (MS) | Subscribers Only | Subscribers Only | Subscribers Only |
| 12/5/23 | Roche (RHHBY) | Inavolisib for HR+/HER2- Breast Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 12/4/23 | Alto Neuroscience | ALTO-300 for Major Depressive Disorder (MDD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 12/1/23 | Pfizer (PFE) | Danuglipron for Obesity | Subscribers Only | Subscribers Only | Subscribers Only |
| 11/30/23 | CG Oncology | CG0070 for Bladder Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 12/08/23 | Subscribers Only | Subscribers Only | Trial Data - Final Results |
| 12/08/23 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 12/08/23 | Subscribers Only | Subscribers Only | Trial Data - Other |
| 12/08/23 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| Now - 12/09/23 | Subscribers Only | Subscribers Only | Trial Data - Other |
